Literature DB >> 26657056

High throughput screening technologies for ion channels.

Hai-bo Yu1, Min Li1, Wei-ping Wang1, Xiao-liang Wang1.   

Abstract

Ion channels are involved in a variety of fundamental physiological processes, and their malfunction causes numerous human diseases. Therefore, ion channels represent a class of attractive drug targets and a class of important off-targets for in vitro pharmacological profiling. In the past decades, the rapid progress in developing functional assays and instrumentation has enabled high throughput screening (HTS) campaigns on an expanding list of channel types. Chronologically, HTS methods for ion channels include the ligand binding assay, flux-based assay, fluorescence-based assay, and automated electrophysiological assay. In this review we summarize the current HTS technologies for different ion channel classes and their applications.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26657056      PMCID: PMC4722985          DOI: 10.1038/aps.2015.108

Source DB:  PubMed          Journal:  Acta Pharmacol Sin        ISSN: 1671-4083            Impact factor:   6.150


  89 in total

1.  A novel series of benzimidazole NR2B-selective NMDA receptor antagonists.

Authors:  David J Davies; Matthew Crowe; Nolwenn Lucas; Joanna Quinn; David D Miller; Sara Pritchard; David Grose; Ezio Bettini; Novella Calcinaghi; Caterina Virginio; Lee Abberley; Paul Goldsmith; Anton D Michel; Iain P Chessell; James N C Kew; Neil D Miller; Martin J Gunthorpe
Journal:  Bioorg Med Chem Lett       Date:  2012-02-06       Impact factor: 2.823

2.  A yellow fluorescent protein-based assay for high-throughput screening of glycine and GABAA receptor chloride channels.

Authors:  Wade Kruger; Daniel Gilbert; Rebecca Hawthorne; Deanne H Hryciw; Stephan Frings; Philip Poronnik; Joseph W Lynch
Journal:  Neurosci Lett       Date:  2005-02-23       Impact factor: 3.046

3.  Novel pharmacological activity of loperamide and CP-339,818 on human HCN channels characterized with an automated electrophysiology assay.

Authors:  Yan T Lee; Dmitry V Vasilyev; Qin J Shan; John Dunlop; Scott Mayer; Mark R Bowlby
Journal:  Eur J Pharmacol       Date:  2007-12-04       Impact factor: 4.432

4.  An ion channel library for drug discovery and safety screening on automated platforms.

Authors:  Barbara A Wible; Yuri A Kuryshev; Stephen S Smith; Zhiqi Liu; Arthur M Brown
Journal:  Assay Drug Dev Technol       Date:  2008-12       Impact factor: 1.738

5.  A fluorescence-based high-throughput screening assay for the identification of T-type calcium channel blockers.

Authors:  Francesco Belardetti; Elizabeth Tringham; Cyrus Eduljee; Xinpo Jiang; Haiheng Dong; Adam Hendricson; Yoko Shimizu; Diana L Janke; David Parker; Janette Mezeyova; Afsheen Khawaja; Hassan Pajouhesh; Robert A Fraser; Stephen P Arneric; Terrance P Snutch
Journal:  Assay Drug Dev Technol       Date:  2009-06       Impact factor: 1.738

6.  Photophysics of the fluorescent K+ indicator PBFI.

Authors:  K Meuwis; N Boens; F C De Schryver; J Gallay; M Vincent
Journal:  Biophys J       Date:  1995-06       Impact factor: 4.033

7.  Identification of ML204, a novel potent antagonist that selectively modulates native TRPC4/C5 ion channels.

Authors:  Melissa Miller; Jie Shi; Yingmin Zhu; Maksym Kustov; Jin-bin Tian; Amy Stevens; Meng Wu; Jia Xu; Shunyou Long; Pu Yang; Alexander V Zholos; James M Salovich; C David Weaver; Corey R Hopkins; Craig W Lindsley; Owen McManus; Min Li; Michael X Zhu
Journal:  J Biol Chem       Date:  2011-07-27       Impact factor: 5.157

8.  A medium-throughput functional assay of KCNQ2 potassium channels using rubidium efflux and atomic absorption spectrometry.

Authors:  Clay W Scott; Deidre E Wilkins; Shephali Trivedi; Denis J Crankshaw
Journal:  Anal Biochem       Date:  2003-08-15       Impact factor: 3.365

9.  Development and validation of fluorescence-based and automated patch clamp-based functional assays for the inward rectifier potassium channel Kir4.1.

Authors:  Rene Raphemot; Rishin J Kadakia; Michelle L Olsen; Sreedatta Banerjee; Emily Days; Stephen S Smith; C David Weaver; Jerod S Denton
Journal:  Assay Drug Dev Technol       Date:  2013-11-22       Impact factor: 1.738

10.  Yellow fluorescent protein-based assay to measure GABA(A) channel activation and allosteric modulation in CHO-K1 cells.

Authors:  Teres Johansson; Tyrrell Norris; Helena Peilot-Sjögren
Journal:  PLoS One       Date:  2013-03-14       Impact factor: 3.240

View more
  30 in total

1.  Ion channels research in the post-genomic era.

Authors:  Bernard Attali; Zhao-Bing Gao
Journal:  Acta Pharmacol Sin       Date:  2016-01       Impact factor: 6.150

Review 2.  Discovery of KV 1.3 ion channel inhibitors: Medicinal chemistry approaches and challenges.

Authors:  Špela Gubič; Louise A Hendrickx; Žan Toplak; Maša Sterle; Steve Peigneur; Tihomir Tomašič; Luis A Pardo; Jan Tytgat; Anamarija Zega; Lucija P Mašič
Journal:  Med Res Rev       Date:  2021-05-01       Impact factor: 12.944

Review 3.  High-Content Assessment of Cardiac Function Using Heart-on-a-Chip Devices as Drug Screening Model.

Authors:  Genevieve Conant; Benjamin Fook Lun Lai; Rick Xing Ze Lu; Anastasia Korolj; Erika Yan Wang; Milica Radisic
Journal:  Stem Cell Rev Rep       Date:  2017-06       Impact factor: 5.739

4.  VU0810464, a non-urea G protein-gated inwardly rectifying K+ (Kir 3/GIRK) channel activator, exhibits enhanced selectivity for neuronal Kir 3 channels and reduces stress-induced hyperthermia in mice.

Authors:  Baovi N Vo; Kristopher K Abney; Allison Anderson; Ezequiel Marron Fernandez de Velasco; Michael A Benneyworth; John Scott Daniels; Ryan D Morrison; Corey R Hopkins; Charles David Weaver; Kevin Wickman
Journal:  Br J Pharmacol       Date:  2019-05-30       Impact factor: 8.739

5.  Full-Spectral Multiplexing of Bioluminescence Resonance Energy Transfer in Three TRPV Channels.

Authors:  Hermanus Johannes Ruigrok; Guillaume Shahid; Bertrand Goudeau; Florence Poulletier de Gannes; Emmanuelle Poque-Haro; Annabelle Hurtier; Isabelle Lagroye; Pierre Vacher; Stéphane Arbault; Neso Sojic; Bernard Veyret; Yann Percherancier
Journal:  Biophys J       Date:  2017-01-10       Impact factor: 4.033

6.  Enhancing inactivation rather than reducing activation of Nav1.7 channels by a clinically effective analgesic CNV1014802.

Authors:  Yue-Ming Zheng; Wan-Fu Wang; Yan-Fen Li; Yong Yu; Zhao-Bing Gao
Journal:  Acta Pharmacol Sin       Date:  2017-11-02       Impact factor: 6.150

7.  Impact of a five-dimensional framework on R&D productivity at AstraZeneca.

Authors:  Paul Morgan; Dean G Brown; Simon Lennard; Mark J Anderton; J Carl Barrett; Ulf Eriksson; Mark Fidock; Bengt Hamrén; Anthony Johnson; Ruth E March; James Matcham; Jerome Mettetal; David J Nicholls; Stefan Platz; Steve Rees; Michael A Snowden; Menelas N Pangalos
Journal:  Nat Rev Drug Discov       Date:  2018-01-19       Impact factor: 84.694

8.  High-Throughput Phenotyping of Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes and Neurons Using Electric Field Stimulation and High-Speed Fluorescence Imaging.

Authors:  Neil J Daily; Zhong-Wei Du; Tetsuro Wakatsuki
Journal:  Assay Drug Dev Technol       Date:  2017-05-19       Impact factor: 1.738

9.  Discovery and in Vitro Optimization of 3-Sulfamoylbenzamides as ROMK Inhibitors.

Authors:  Matthew F Sammons; Sujay V Kharade; Kevin J Filipski; Markus Boehm; Aaron C Smith; Andre Shavnya; Dilinie P Fernando; Matthew S Dowling; Philip A Carpino; Neil A Castle; Shannon G Zellmer; Brett M Antonio; James R Gosset; Anthony Carlo; Jerod S Denton
Journal:  ACS Med Chem Lett       Date:  2018-01-19       Impact factor: 4.345

Review 10.  Cardiovascular disease models: A game changing paradigm in drug discovery and screening.

Authors:  Houman Savoji; Mohammad Hossein Mohammadi; Naimeh Rafatian; Masood Khaksar Toroghi; Erika Yan Wang; Yimu Zhao; Anastasia Korolj; Samad Ahadian; Milica Radisic
Journal:  Biomaterials       Date:  2018-10-01       Impact factor: 12.479

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.